Vasc Spec Int.  2016 Dec;32(4):186-189. 10.5758/vsi.2016.32.4.186.

Successful Anticoagulation Therapy for Antiphospholipid Syndrome with Mobile Aortic Thrombi

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, College of Medicine and Institute of Health Sciences, Gyeongsang National University Changwon Hospital, Changwon, Korea. hoya_m@naver.com
  • 2Department of Thoracic and Cardiovascular Surgery, College of Medicine and Institute of Health Sciences, Gyeongsang National University Hospital, Jinju, Korea.

Abstract

Hypercoagulable states have been associated with aortic thrombosis. Antiphospholipid syndrome (APS) is one of the commonest types of acquired thrombophilia. We report the case of successful anticoagulation management in an APS patient with mobile thrombi within the aorta. A 58-year-old male patient presented to the emergency department (ED) with right-sided hemiparesis. His first symptoms were noted approximately 12-16 hours before presentation to the ED. Magnetic resonance imaging of the brain showed acute embolic infarction of the left frontal and parietotemporal lobes. Transesophageal echocardiography (TEE) and computed tomography angiography (CTA) demonstrated mobile thrombi attached to the wall of the ascending aorta and aortic arch. The patient was diagnosed with APS based on positivity of anti-beta-2 glycoprotein 1 antibodies, and was initiated on anticoagulation therapy. Repeated TEE and CTA revealed complete resolution of the thrombi after 12 days of treatment; the patient was discharged well.

Keyword

Aorta; Thrombosis; Antiphospholipid syndrome

MeSH Terms

Angiography
Antibodies
Antiphospholipid Syndrome*
Aorta
Aorta, Thoracic
Brain
Echocardiography, Transesophageal
Emergency Service, Hospital
Glycoproteins
Humans
Infarction
Magnetic Resonance Imaging
Male
Middle Aged
Paresis
Thrombophilia
Thrombosis
Antibodies
Glycoproteins
Full Text Links
  • VSI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr